- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:06 | Avalon GloboCare closes $3.25 million private placement | 8 | Investing.com | ||
| AVALON GLOBOCARE Aktie jetzt für 0€ handeln | |||||
| Fr | Avalon GloboCare Corp.: Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules | 2 | GlobeNewswire (USA) | ||
| Fr | Avalon GloboCare: Aktie stürzt nach verwässernder Privatplatzierung ab | 2 | Investing.com Deutsch | ||
| Fr | Avalon GloboCare announces $9.75M private placement | 1 | Seeking Alpha | ||
| Fr | Avalon GloboCare prices $3.25M private placement at $0.51/share | 2 | Investing.com | ||
| Fr | Avalon GloboCare Corp.: Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| Do | Avalon GloboCare joins AMD AI developer program | 7 | Investing.com | ||
| Do | Avalon GloboCare Corp.: Avalon GloboCare's Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure | 14 | GlobeNewswire (USA) | ||
| Do | EXCLUSIVE: Avalon GloboCare Partners With AMD To Supercharge AI | 13 | Benzinga.com | ||
| Mi | Avalon GloboCare schließt Finanzierungsvereinbarung über 233.910 $ ab und gibt Wechsel im Verwaltungsrat bekannt | 3 | Investing.com Deutsch | ||
| Mi | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.02. | Avalon GloboCare Corp.: Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang | 70 | GlobeNewswire (Europe) | Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J.,... ► Artikel lesen | |
| 02.02. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Avalon GloboCare Corp.: Avalon GloboCare's Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary | 1 | GlobeNewswire (USA) | ||
| 21.01. | FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer | 2 | Benzinga.com | ||
| 20.01. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.01. | Avalon GloboCare erneuert FDA-Registrierung für Keto-Atemmessgerät KetoAir | 1 | Investing.com Deutsch | ||
| 12.01. | Avalon GloboCare Corp.: Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform | 152 | GlobeNewswire (Europe) | FREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer... ► Artikel lesen | |
| 12.01. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 93,10 | -0,21 % | Bayer Aktie: Alles vorbei? - Airbus, BB Biotech, BioNTech, TUI und Valneva - Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| EVOTEC | 5,880 | +0,38 % | Evotec Aktie vor dem Durchbruch? Diesmal ist etwas anders... | Die Evotec Aktie hat zuletzt ein wichtiges Muster bestätigt: Wiederholt scheiterte die Biotech-Aktie aus Hamburg mit Breakversuchen an der 200-Tage-Linie. Nach mehr oder weniger starken Ausbrüchen hierüber... ► Artikel lesen | |
| AMGEN | 328,50 | -0,02 % | Is Amgen Stock Outperforming the Dow? | ||
| VIKING THERAPEUTICS | 28,340 | -1,19 % | Viking Therapeutics: The High-Stakes Weight Loss Contender | ||
| DEFENCE THERAPEUTICS | 0,371 | -1,85 % | Defence Therapeutics Inc.: Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million | Montreal, Quebec--(Newsfile Corp. - February 27, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,420 | -1,18 % | NurExone Biologic: Pionier in der Exosomen-Medizin! | ||
| ABIVAX | 101,80 | -0,97 % | EQS-News: ABIVAX: Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 | EQS-News: ABIVAX
/ Key word(s): Study results
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory... ► Artikel lesen | |
| IDEXX LABORATORIES | 556,20 | +0,04 % | Here's What Analysts Are Saying About IDEXX Laboratories (IDXX) | ||
| IBIO | 2,420 | +0,83 % | iBio, Inc. - 8-K, Current Report | ||
| ARROWHEAD PHARMACEUTICALS | 53,62 | +0,15 % | S&P Dow Jones Indices: Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 | NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:
S&P MidCap 400... ► Artikel lesen | |
| BIOXCEL THERAPEUTICS | 1,400 | -0,71 % | BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI | NEW HAVEN, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence ("AI") to develop transformative medicines... ► Artikel lesen | |
| VOYAGER THERAPEUTICS | 3,426 | -1,44 % | Voyager Therapeutics, Inc.: Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia | CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally "undruggable" targets by leveraging biomolecular... ► Artikel lesen | |
| CYBIN | 6,000 | -1,64 % | Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee | In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus' novel serotonergic agonist ("NSA") portfolio This news release constitutes... ► Artikel lesen | |
| ADAPTIMMUNE THERAPEUTICS | 0,013 | 0,00 % | Adaptimmune Therapeutics PLC: Adaptimmune Announces Changes to Board and Executive Leadership Team | Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - November 17, 2025) - Adaptimmune Therapeutics plc (OTC Pink: ADAPY) ("Adaptimmune" or the "Company") today announced changes... ► Artikel lesen | |
| ANAVEX LIFE SCIENCES | 3,701 | -1,41 % | Anavex Life Sciences Corp.: Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors | NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments... ► Artikel lesen |
Das Unternehmen AVALON GLOBOCARE CORP kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,400 (+36,70 %) liegt der Kurs bei 1,490 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AVALON GLOBOCARE CORP finden Sie auf Wallstreet Online.